SynthesisScientific reports2017

Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials.

Li Jun Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.